In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Outlook 2022

Annual industry ranking and forecast

US Forming Industry Consortia To Prepare For Future Pandemics And Global Supply Chain Disruptions

Executive Summary

HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.

You may also be interested in...

Brookings’ Drug Shortages Remedies Target Both Hospitals And Manufacturers

Incentives would give hospitals reason to pay for quality and reliability, while loans would help generics manufacturers upgrade sterile injectables facilities and feds would buffer supply chains with additional inventories, the policy think tank says. All it would take is an act of Congress.

Supply Chain Conversations Should Continue, But Industry Wants More Government Transparency

Healthcare Distribution Alliance CEO Chip Davis says drug wholesalers and suppliers need the government’s information on product demand, just as the government needs industry inventory data, to anticipate and avert shortages.

US FDA Looks To Resume Unannounced Inspections In India And China

After lapsing due to COVID-19, an unannounced foreign inspection pilot program is on track to resume in 2022, “despite challenges and constraints of travel.”

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts